The UK geriatric medicine market is projected to witness considerable growth during the forecast period. The major factors contributing to the growth of the market include the increasing geriatric population and rising prevalence of chronic diseases, such as cancer and cardiovascular diseases (CVDs). Geriatric Medicine is one of the major specialties in the UK. It is currently regarded as one of the largest specialties in hospital medicine, with a strong academic base. 

With the large presence of market players and research institutes, the country has over 15 academic institutes that focus on geriatric medical studies. Therefore, considerable growth can be expected for the geriatric medicine market in UK during the forecast period. Moreover, the Geriatric Medicine Programme by the Government of UK is further contributing to the development and demand for geriatric medicine in the country. 

The geriatric medicine market is classified on the basis of therapeutics and conditions. Based on therapeutics, the market is segmented into analgesic, anticoagulant, antihypertensive, antidiabetic, and others. Based on the condition, the market is segregated into CVDs, diabetes, neurological, cancer, respiratory, and others. Among these conditions, the CVDs segment contributes significantly to the market. The dominance of the segment is backed by the significant patient pool of CVDs across the globe. With the rise in age, the development of CVDs increases subsequently. Therefore, a huge market is covered by CVDs medicines in the geriatric medicine market. 

The UK geriatric medicine market is influenced by product development and advancements conducted by the market players. Some of the global key players of the geriatric medicine market include Novartis AG, GlaxoSmithKline Plc, Merck & Co. Inc., Sanofi SA, Pfizer Inc., Johnson & Johnson Services Inc., Boehringer Ingelheim GmbH, and AstraZeneca PLC. These players are playing a significant role in the growth of the geriatric medicine market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, technological development, and others.

Research Methodology

The market study of the UK geriatric medicine market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

• Financial reports of companies involved in the market
• Whitepapers, research-papers, and news blogs
• Company websites and their product catalog

The report is intended for drug manufacturers, pharmaceutical & biopharmaceutical companies, research institutes, academic institutes, industry associates & experts, government organizations, regulatory bodies, and other market participants for overall market analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. UK Geriatric Medicine Market Research and Analysis by Therapeutics
2. UK Geriatric Medicine Market Research and Analysis by Condition

The Report covers:

• Comprehensive research methodology of the UK geriatric medicine market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the UK geriatric medicine market.
• Insights about market determinants which are stimulating the UK market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.